School of Nursing and Midwifery, Trinity College Dublin, Dublin, Ireland.
NuMIQ research focus area: Research to promote quality of Nursing and Midwifery, North-West University, Potchefstroom, South Africa.
PLoS One. 2020 Jul 28;15(7):e0227941. doi: 10.1371/journal.pone.0227941. eCollection 2020.
To compare synthetic oxytocin infusion regimens used during labour, calculate the International Units (IU) escalation rate and total amount of IU infused over eight hours.
Observational study.
Twelve countries, eleven European and South Africa.
National, regional or institutional-level regimens on oxytocin for induction and augmentation labour.
Data on oxytocin IU dose, infusion fluid amount, start dose, escalation rate and maximum dose were collected. Values for each regimen were converted to IU in 1000ml diluent. One IU corresponded to 1.67μg for doses provided in grams/micrograms. IU hourly dose increase rates were based on escalation frequency. Cumulative doses and total IU amount infused were calculated by adding the dose administered for each previous hour. Main Outcome Measures Oxytocin IU dose infused.
Data were obtained on 21 regimens used in 12 countries. Details on the start dose, escalation interval, escalation rate and maximum dose infused were available from 16 regimens. Starting rates varied from 0.06 IU/hour to 0.90 IU/hour, and the maximum dose rate varied from 0.90 IU/hour to 3.60 IU/hour. The total amount of IU oxytocin infused, estimated over eight hours, ranged from 2.38 IU to 27.00 IU, a variation of 24.62 IU and an 11-fold difference.
Current variations in oxytocin regimens for induction and augmentation of labour are inexplicable. It is crucial that the appropriate minimum infusion regimen is administered because synthetic oxytocin is a potentially harmful medication with serious consequences for women and babies when inappropriately used. Estimating the total amount of oxytocin IU received by labouring women, alongside the institution's mode of birth and neonatal outcomes, may deepen our understanding and be the way forward to identifying the optimal infusion regimen.
比较分娩时使用的合成催产素输注方案,计算国际单位 (IU) 递增率和 8 小时内输注的总 IU 量。
观察性研究。
12 个国家,11 个欧洲国家和南非。
催产素用于引产和加强分娩的国家、地区或机构级方案。
收集催产素 IU 剂量、输注液量、起始剂量、递增率和最大剂量的数据。每个方案的值均转换为 1000ml 稀释剂中的 IU。每 1IU 相当于提供的克/微克剂量的 1.67μg。IU 每小时剂量增加率基于递增频率。通过将前一小时给予的剂量相加来计算累积剂量和总 IU 量。
输注的催产素 IU 剂量。
在 12 个国家使用的 21 种方案中获得了数据。16 种方案提供了起始剂量、递增间隔、递增率和最大剂量输注的详细信息。起始率从 0.06IU/小时到 0.90IU/小时不等,最大剂量率从 0.90IU/小时到 3.60IU/小时不等。估计在 8 小时内输注的催产素 IU 总量从 2.38IU 到 27.00IU 不等,差异为 24.62IU,相差 11 倍。
目前用于引产和加强分娩的催产素方案差异无法解释。至关重要的是,应给予适当的最低输注方案,因为合成催产素是一种潜在有害的药物,如果使用不当,会对妇女和婴儿造成严重后果。估计接受催产素的产妇接受的 IU 总量,以及机构的分娩模式和新生儿结局,可以加深我们的理解,并为确定最佳输注方案提供方向。